GM, Stellantis shares fall after Trump’s auto tariff announcement

GM, Stellantis shares fall after Trump’s auto tariff announcement


The border wall is shown in a background as a semi-truck carrying Toyota trucks crosses a bridge after clearing U.S. Customs while entering the United States from Mexico along the border in San Diego, California, U.S., March 4, 2025. 

Mike Blake | Reuters

Auto stocks are digesting President Donald Trump’s announcement that he would place 25% tariffs on “all cars that are not made in the United States,” as well as certain automobile parts.

Trump’s administration had been telegraphing plans to put tariffs on the auto industry, but the impact of those moves and mechanism for enforcement are starting to take sharp. Trump said the tariffs would go into effect April 2.

General Motors stock was down about 6% in early trading Thursday, while Stellantis lost more than 1%. Tesla, however, was marginally higher while Ford Motor shares hovered around the flat line.

“In our coverage, for [original equipment manufacturers], Tesla and Ford appear to be the most shielded given location of vehicle assembly facilities although Ford does face incremental exposure on imported engines,” Deutsche Bank analysts wrote in a note Thursday. “GM has the most exposure to Mexico.”

Trump said Wednesday he would not put a tariff on vehicles that are built in the U.S.

The tariffs apply to imported passenger vehicles and light trucks, as well as key automobile parts including engines and transmissions, the White House said in a fact sheet.

Auto executive tells CNBC auto tariffs will drive auto industry into recession

Vehicles are made up of tens of thousands of parts, many of which cross back and forth over the U.S. border before a final product is completed.

Data and forecasting firm S&P Global Mobility reports there are on average 20,000 parts in a vehicle when it’s torn down to its nuts and bolts. Parts may originate in anywhere from 50 to 120 countries.

The firm also reports that 25 automakers on average produce 63,900 light-duty passenger vehicles in North America per day. A majority of those, roughly 65%, are assembled in the U.S., followed by 27% in Mexico and 8% in Canada.

Goldman Sachs analysts wrote Thursday that Trump’s 25% tariff could raise the price of imported cars by $5,000 to $15,000. If roughly 50% of parts in a U.S.-made car came from foreign sources, the tariff could raise the price of those cars by $3,000 to $8,000, they added.

The President had previously granted automakers a one-month tariff exemption for vehicles that comply with the United States-Mexico-Canada Agreement’s trade rules of origin.

— CNBC’s Michael Wayland and Michael Bloom contributed to this report.



Source

Fabletics launches denim as the athleisure trade loses steam
Business

Fabletics launches denim as the athleisure trade loses steam

Athletic apparel maker Fabletics is launching its first denim collection, the company announced Tuesday, signaling the once white hot athleisure category is starting to slow down. The collection, launching online and in select stores on Thursday, will include 11 styles and seven washes across both women’s and men’s. Items will be priced between $79.95 and […]

Read More
Boaz Weinstein warns of private credit’s “financial alchemy,” says problems are multiplying by the quarter
Business

Boaz Weinstein warns of private credit’s “financial alchemy,” says problems are multiplying by the quarter

A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. The problems in private credit are “multiplying by the quarter,” due in part to the […]

Read More
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment
Business

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children.  The move […]

Read More